BJO

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Published Online First: 29 June 2006. doi:10.1136/bjo.2006.094912
British Journal of Ophthalmology 2006;90:1366-1369
Copyright © 2006 by the BMJ Publishing Group Ltd.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
bjo.2006.094912v1
90/11/1366    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Souchier, M
Right arrow Articles by Creuzot-Garcher, C
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Souchier, M
Right arrow Articles by Creuzot-Garcher, C

EXTENDED REPORT

Trefoil factor family 1, MUC5AC and human leucocyte antigen-DR expression by conjunctival cells in patients with glaucoma treated with chronic drugs: could these markers predict the success of glaucoma surgery?

M Souchier1, N Buron2, P O Lafontaine1, A M Bron1, C Baudouin3, C Creuzot-Garcher1

1 Department of Ophthalmology, University Hospital, Dijon, France
2 INSERM U 517, University Hospital
3 Centre Hospitalier National d’Ophtalmologie des Quinze Vingts, Paris, France

Correspondence to:
Correspondence to:
A M Bron
Service d’Ophtalmologie, Hôpital Général, 21000 Dijon, France;alain.bron{at}chu-dijon.fr

Aims: To evaluate conjunctival expression of trefoil factor family (TFF)1, MUC5AC and human leucocyte antigen (HLA)-DR in patients with glaucoma treated with topical drugs, and to determine whether these parameters can predict the outcome of glaucoma surgery.

Methods: 77 conjunctival impression cytology specimens were collected from 77 patients with glaucoma (66 receiving drops with preservative and 11 treated with preservative-free drops) and 43 controls. TFF1, MUC5AC and HLA-DR expression was analysed using flow cytometry. Trabeculectomy was performed in 56 patients; success was defined as an intraocular pressure (IOP) <=15 mm Hg without any IOP-lowering drug at 6 months.

Results: The expression of TFF1, MUC5AC and HLA-DR was significantly higher in patients than in controls (p = 0.01, 0.05 and 0.004, respectively). A higher expression of MUC5AC was found in patients treated with preserved drops than in those receiving unpreserved drops (p = 0.04). A higher MUC5AC expression and a lower HLA-DR expression was observed in successful glaucoma surgeries than in failures.

Conclusions: TFF1 and MUC5AC secretions are probably a response to mild ocular surface changes caused by long-term use of topical treatment. Their increased expression could be a predicting factor of further successful glaucoma surgery.


Abbreviations: HLA, human leucocyte antigen; IOP, intraocular pressure; PBS, phosphate-buffered saline; TTF, trefoil factor family







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2006 by the BMJ Publishing Group Ltd.